therapeutics 相關
廣告- AAV Vector
Adeno-associated Virus Vector
Design, Construction, Titration
- Adeno-Associated Virus
Recombinant AAV Vector for Research
AAV Vector for Gene Therapy
- Viral Vector Construction
Lentivirus, Adenovirus, AAV Vector
HSV, VACV, Baculovirus Vector
- Potency Tests
Preclinical In Vitro Assays
Preclinical In Vivo Studies
- Preclinical In Vivo Study
Xenograft Animal Models
Biodistribution, Efficacy, Toxicity
- Baculovirus Vector
Circumvent vector neutralization
High titers, large Insert capacity
- AAV Vector
搜尋結果
生物製藥公司Actuate Therapeutics(ACTU.US)申請美股IPO 擬籌資5000萬美元
阿思達克財經網· 6 小時前智通財經APP獲悉,生物製藥公司Actuate Therapeutics(ACTU.US)致力於開發用於治療癌症和炎症性疾病的化合...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 2 日前There's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 2 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
Tech driven biology and chemistry: Solving science’s hardest problems at scale | TechCrunch
TechCrunch· 2 日前Join leaders in the AI-Driven Drug Discovery market for a fireside chat exploring how to build ...
Tango Therapeutics to stop development of cancer therapy
Reuters· 2 日前, opens new tab said on Thursday it would stop the development of its experimental cancer therapy due to liver toxicity ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 3 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
InnovationRx: Under 30 Alum Raises $35 Million For Virtual Addiction Treatment
Forbes· 3 日前InnovationRx is your weekly digest of healthcare news. Stephanie Papes Strong took the opposite ...
Up 165% This Year, Will Dyne Therapeutics Continue Its Stellar Run?
Forbes· 3 日前... biotechnology company focused on advancing genetically driven muscle diseases therapeutics ...
Cramer's Lightning Round: Lazard is a buy
CNBC· 4 日前"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at ...
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 4 日前Structure Therapeutics is an overlooked player in the GLP-1 market, and could one day boast a ...